Concepts (225)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Food Assistance | 3 | 2021 | 36 | 1.030 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 7 | 2025 | 1198 | 1.030 |
Why?
|
| Mass Screening | 2 | 2023 | 782 | 0.960 |
Why?
|
| Aftercare | 1 | 2023 | 147 | 0.750 |
Why?
|
| Cytomegalovirus | 2 | 2023 | 270 | 0.720 |
Why?
|
| BK Virus | 1 | 2021 | 60 | 0.710 |
Why?
|
| Food Supply | 2 | 2021 | 101 | 0.700 |
Why?
|
| Cystitis | 1 | 2021 | 50 | 0.700 |
Why?
|
| Food Services | 1 | 2020 | 39 | 0.690 |
Why?
|
| Polyomavirus Infections | 1 | 2021 | 90 | 0.690 |
Why?
|
| Tumor Virus Infections | 1 | 2021 | 135 | 0.690 |
Why?
|
| Homeless Youth | 1 | 2019 | 13 | 0.630 |
Why?
|
| Influenza Vaccines | 4 | 2025 | 478 | 0.620 |
Why?
|
| Caregivers | 5 | 2024 | 560 | 0.620 |
Why?
|
| Social Stigma | 1 | 2019 | 69 | 0.600 |
Why?
|
| Health Policy | 1 | 2020 | 213 | 0.600 |
Why?
|
| Human Trafficking | 1 | 2019 | 42 | 0.590 |
Why?
|
| Influenza, Human | 4 | 2025 | 657 | 0.570 |
Why?
|
| Lung Transplantation | 1 | 2021 | 321 | 0.560 |
Why?
|
| Staphylococcus aureus | 2 | 2013 | 458 | 0.530 |
Why?
|
| Job Syndrome | 1 | 2016 | 17 | 0.530 |
Why?
|
| Heart Transplantation | 4 | 2023 | 855 | 0.480 |
Why?
|
| STAT3 Transcription Factor | 1 | 2016 | 222 | 0.460 |
Why?
|
| Child | 26 | 2025 | 24372 | 0.440 |
Why?
|
| Health Personnel | 1 | 2019 | 504 | 0.440 |
Why?
|
| Staphylococcal Skin Infections | 1 | 2013 | 39 | 0.430 |
Why?
|
| Community-Acquired Infections | 2 | 2013 | 241 | 0.430 |
Why?
|
| Immunogenicity, Vaccine | 4 | 2025 | 102 | 0.420 |
Why?
|
| Heart-Assist Devices | 4 | 2023 | 1021 | 0.410 |
Why?
|
| Soft Tissue Infections | 1 | 2013 | 85 | 0.410 |
Why?
|
| Child, Hospitalized | 2 | 2024 | 71 | 0.400 |
Why?
|
| Influenza A Virus, H1N1 Subtype | 2 | 2024 | 178 | 0.390 |
Why?
|
| Emigrants and Immigrants | 2 | 2024 | 143 | 0.380 |
Why?
|
| Methicillin-Resistant Staphylococcus aureus | 1 | 2013 | 221 | 0.360 |
Why?
|
| Transplant Recipients | 4 | 2024 | 216 | 0.310 |
Why?
|
| Clostridium Infections | 2 | 2022 | 245 | 0.280 |
Why?
|
| Humans | 34 | 2025 | 124610 | 0.270 |
Why?
|
| Antibodies, Viral | 4 | 2025 | 1151 | 0.260 |
Why?
|
| Leukocidins | 1 | 2006 | 37 | 0.250 |
Why?
|
| Exotoxins | 1 | 2006 | 44 | 0.250 |
Why?
|
| Child, Preschool | 13 | 2025 | 14009 | 0.250 |
Why?
|
| Endocarditis, Bacterial | 2 | 2018 | 133 | 0.250 |
Why?
|
| Texas | 3 | 2021 | 3584 | 0.240 |
Why?
|
| Spleen | 2 | 2016 | 281 | 0.240 |
Why?
|
| Ganciclovir | 2 | 2023 | 103 | 0.240 |
Why?
|
| Heart Failure | 3 | 2023 | 2283 | 0.230 |
Why?
|
| Retrospective Studies | 9 | 2023 | 16316 | 0.220 |
Why?
|
| Lymphopenia | 1 | 2023 | 36 | 0.210 |
Why?
|
| Osteomyelitis | 1 | 2006 | 205 | 0.210 |
Why?
|
| Fecal Microbiota Transplantation | 2 | 2022 | 98 | 0.200 |
Why?
|
| Antiviral Agents | 3 | 2023 | 748 | 0.200 |
Why?
|
| Fasciitis, Necrotizing | 1 | 2022 | 27 | 0.190 |
Why?
|
| Myelitis | 1 | 2022 | 15 | 0.190 |
Why?
|
| Neutropenia | 1 | 2023 | 200 | 0.190 |
Why?
|
| Enterovirus | 1 | 2022 | 52 | 0.190 |
Why?
|
| Myositis | 1 | 2022 | 62 | 0.190 |
Why?
|
| Undocumented Immigrants | 1 | 2021 | 12 | 0.190 |
Why?
|
| Enterovirus Infections | 1 | 2022 | 48 | 0.180 |
Why?
|
| Cell- and Tissue-Based Therapy | 1 | 2023 | 158 | 0.180 |
Why?
|
| Cytomegalovirus Infections | 1 | 2023 | 218 | 0.180 |
Why?
|
| Pneumococcal Infections | 1 | 2023 | 275 | 0.180 |
Why?
|
| Organ Transplantation | 1 | 2023 | 167 | 0.180 |
Why?
|
| Staphylococcal Infections | 1 | 2006 | 557 | 0.180 |
Why?
|
| Adolescent | 8 | 2025 | 19277 | 0.170 |
Why?
|
| Young Adult | 6 | 2025 | 9013 | 0.170 |
Why?
|
| Meals | 1 | 2020 | 57 | 0.170 |
Why?
|
| Virus Diseases | 1 | 2023 | 280 | 0.170 |
Why?
|
| Fear | 1 | 2021 | 199 | 0.170 |
Why?
|
| Spike Glycoprotein, Coronavirus | 1 | 2021 | 190 | 0.160 |
Why?
|
| Vulnerable Populations | 1 | 2020 | 140 | 0.160 |
Why?
|
| Patient Discharge | 1 | 2023 | 489 | 0.160 |
Why?
|
| Overweight | 1 | 2021 | 363 | 0.150 |
Why?
|
| Medicaid | 1 | 2021 | 242 | 0.150 |
Why?
|
| Single Photon Emission Computed Tomography Computed Tomography | 1 | 2018 | 7 | 0.150 |
Why?
|
| Schools | 1 | 2020 | 220 | 0.150 |
Why?
|
| Recurrence | 3 | 2022 | 1420 | 0.150 |
Why?
|
| Health Services Accessibility | 1 | 2023 | 606 | 0.150 |
Why?
|
| Rural Population | 1 | 2020 | 256 | 0.150 |
Why?
|
| Hospitals | 1 | 2021 | 388 | 0.150 |
Why?
|
| Parents | 2 | 2024 | 1015 | 0.150 |
Why?
|
| Herpesvirus 4, Human | 2 | 2023 | 676 | 0.150 |
Why?
|
| Infant | 6 | 2024 | 12468 | 0.140 |
Why?
|
| Fluorodeoxyglucose F18 | 1 | 2018 | 144 | 0.140 |
Why?
|
| Immunocompromised Host | 1 | 2019 | 293 | 0.140 |
Why?
|
| Smoking | 1 | 2023 | 1045 | 0.140 |
Why?
|
| Risk Factors | 3 | 2021 | 10269 | 0.140 |
Why?
|
| Phosphotyrosine | 1 | 2016 | 23 | 0.140 |
Why?
|
| Betacoronavirus | 1 | 2020 | 287 | 0.140 |
Why?
|
| Heat Shock Transcription Factors | 1 | 2016 | 19 | 0.130 |
Why?
|
| Social Determinants of Health | 1 | 2018 | 124 | 0.130 |
Why?
|
| Female | 15 | 2025 | 66492 | 0.130 |
Why?
|
| Diterpenes | 1 | 2016 | 28 | 0.130 |
Why?
|
| Half-Life | 1 | 2016 | 158 | 0.130 |
Why?
|
| Healthcare Disparities | 1 | 2021 | 429 | 0.130 |
Why?
|
| Kidney Transplantation | 1 | 2022 | 643 | 0.130 |
Why?
|
| Protein Stability | 1 | 2016 | 162 | 0.130 |
Why?
|
| Education, Medical, Undergraduate | 1 | 2018 | 168 | 0.130 |
Why?
|
| Mutant Proteins | 1 | 2016 | 115 | 0.130 |
Why?
|
| Prosthesis-Related Infections | 1 | 2018 | 177 | 0.130 |
Why?
|
| Interleukin-17 | 1 | 2016 | 120 | 0.130 |
Why?
|
| Immunoglobulin G | 2 | 2023 | 777 | 0.130 |
Why?
|
| Stroke | 1 | 2023 | 984 | 0.120 |
Why?
|
| Adult | 9 | 2025 | 29437 | 0.120 |
Why?
|
| Cough | 1 | 2016 | 87 | 0.120 |
Why?
|
| Coronavirus Infections | 1 | 2020 | 358 | 0.120 |
Why?
|
| Pneumonia, Viral | 1 | 2020 | 372 | 0.120 |
Why?
|
| Male | 12 | 2025 | 61198 | 0.120 |
Why?
|
| Transposition of Great Vessels | 1 | 2015 | 130 | 0.110 |
Why?
|
| CD8-Positive T-Lymphocytes | 1 | 2016 | 396 | 0.110 |
Why?
|
| Device Removal | 1 | 2015 | 221 | 0.110 |
Why?
|
| Diarrhea | 1 | 2016 | 317 | 0.110 |
Why?
|
| Electrophoresis, Gel, Pulsed-Field | 1 | 2013 | 92 | 0.110 |
Why?
|
| Eczema | 1 | 2013 | 29 | 0.110 |
Why?
|
| CD4-Positive T-Lymphocytes | 1 | 2016 | 473 | 0.110 |
Why?
|
| Students, Medical | 1 | 2018 | 357 | 0.110 |
Why?
|
| Influenza A Virus, H3N2 Subtype | 2 | 2024 | 115 | 0.110 |
Why?
|
| Models, Molecular | 1 | 2016 | 1069 | 0.100 |
Why?
|
| Pandemics | 1 | 2020 | 1099 | 0.100 |
Why?
|
| Crohn Disease | 1 | 2016 | 283 | 0.100 |
Why?
|
| Protein Binding | 1 | 2016 | 1738 | 0.100 |
Why?
|
| Chi-Square Distribution | 1 | 2013 | 587 | 0.100 |
Why?
|
| Pulmonary Artery | 1 | 2015 | 441 | 0.100 |
Why?
|
| Antibody Formation | 2 | 2024 | 266 | 0.100 |
Why?
|
| Treatment Outcome | 5 | 2023 | 12324 | 0.100 |
Why?
|
| United States | 3 | 2024 | 10889 | 0.100 |
Why?
|
| Heart Defects, Congenital | 1 | 2023 | 1813 | 0.100 |
Why?
|
| Heart Valve Prosthesis Implantation | 1 | 2015 | 436 | 0.090 |
Why?
|
| Heart Ventricles | 1 | 2015 | 762 | 0.090 |
Why?
|
| Cytokines | 1 | 2016 | 1291 | 0.090 |
Why?
|
| Inpatients | 2 | 2024 | 496 | 0.070 |
Why?
|
| Middle Aged | 4 | 2024 | 26713 | 0.070 |
Why?
|
| DNA-Binding Proteins | 1 | 2016 | 2045 | 0.070 |
Why?
|
| Vaccination | 2 | 2025 | 954 | 0.070 |
Why?
|
| Lung | 1 | 2016 | 1491 | 0.070 |
Why?
|
| Vaccines | 1 | 2023 | 366 | 0.070 |
Why?
|
| Postoperative Complications | 1 | 2019 | 3065 | 0.070 |
Why?
|
| Blood Vessel Prosthesis Implantation | 1 | 2015 | 803 | 0.070 |
Why?
|
| Transcription Factors | 1 | 2016 | 2584 | 0.070 |
Why?
|
| Adhesins, Bacterial | 1 | 2006 | 75 | 0.060 |
Why?
|
| Methicillin Resistance | 1 | 2006 | 118 | 0.060 |
Why?
|
| Bacterial Toxins | 1 | 2006 | 175 | 0.060 |
Why?
|
| Cross-Sectional Studies | 2 | 2024 | 3423 | 0.060 |
Why?
|
| Infant, Newborn | 2 | 2015 | 8191 | 0.060 |
Why?
|
| Hemagglutination Inhibition Tests | 1 | 2024 | 114 | 0.050 |
Why?
|
| Hunger | 1 | 2024 | 50 | 0.050 |
Why?
|
| Body Surface Area | 1 | 2023 | 31 | 0.050 |
Why?
|
| Vaccines, Conjugate | 1 | 2023 | 78 | 0.050 |
Why?
|
| Vaccines, Inactivated | 1 | 2024 | 145 | 0.050 |
Why?
|
| Mutation | 1 | 2016 | 5826 | 0.050 |
Why?
|
| Leukocytes, Mononuclear | 1 | 2024 | 325 | 0.050 |
Why?
|
| Acute Disease | 1 | 2006 | 1110 | 0.050 |
Why?
|
| Age Factors | 2 | 2021 | 2818 | 0.050 |
Why?
|
| Pneumococcal Vaccines | 1 | 2023 | 169 | 0.050 |
Why?
|
| Professional-Family Relations | 1 | 2002 | 92 | 0.050 |
Why?
|
| Diagnosis, Differential | 2 | 2018 | 1882 | 0.050 |
Why?
|
| Antibodies, Bacterial | 1 | 2023 | 388 | 0.050 |
Why?
|
| Thinness | 1 | 2021 | 70 | 0.050 |
Why?
|
| Morbidity | 1 | 2022 | 247 | 0.050 |
Why?
|
| Outpatients | 1 | 2022 | 251 | 0.040 |
Why?
|
| Membrane Transport Proteins | 1 | 2002 | 176 | 0.040 |
Why?
|
| Qualitative Research | 1 | 2023 | 539 | 0.040 |
Why?
|
| RNA, Ribosomal, 16S | 1 | 2022 | 369 | 0.040 |
Why?
|
| Health Care Surveys | 1 | 2021 | 287 | 0.040 |
Why?
|
| Epstein-Barr Virus Infections | 1 | 2023 | 293 | 0.040 |
Why?
|
| Mice | 1 | 2016 | 17639 | 0.040 |
Why?
|
| Double-Blind Method | 1 | 2023 | 1637 | 0.040 |
Why?
|
| Animals | 3 | 2016 | 34087 | 0.040 |
Why?
|
| Body Weight | 1 | 2023 | 996 | 0.040 |
Why?
|
| Hospitals, Pediatric | 1 | 2024 | 769 | 0.040 |
Why?
|
| Patient Education as Topic | 1 | 2002 | 437 | 0.040 |
Why?
|
| Feces | 1 | 2022 | 725 | 0.040 |
Why?
|
| Health Knowledge, Attitudes, Practice | 1 | 2024 | 841 | 0.040 |
Why?
|
| Poverty | 1 | 2021 | 422 | 0.040 |
Why?
|
| Radiopharmaceuticals | 1 | 2018 | 162 | 0.040 |
Why?
|
| Sexual Behavior | 1 | 2018 | 244 | 0.030 |
Why?
|
| Drosophila melanogaster | 1 | 2002 | 771 | 0.030 |
Why?
|
| Drosophila Proteins | 1 | 2002 | 716 | 0.030 |
Why?
|
| Nausea | 1 | 2016 | 83 | 0.030 |
Why?
|
| Infliximab | 1 | 2016 | 67 | 0.030 |
Why?
|
| Body Mass Index | 1 | 2021 | 1561 | 0.030 |
Why?
|
| Gastrointestinal Agents | 1 | 2016 | 60 | 0.030 |
Why?
|
| Hospitalization | 1 | 2024 | 1777 | 0.030 |
Why?
|
| Vomiting | 1 | 2016 | 105 | 0.030 |
Why?
|
| Heterografts | 1 | 2015 | 171 | 0.030 |
Why?
|
| Allografts | 1 | 2015 | 192 | 0.030 |
Why?
|
| Fatigue | 1 | 2016 | 188 | 0.030 |
Why?
|
| Prosthesis Failure | 1 | 2015 | 158 | 0.030 |
Why?
|
| Bioprosthesis | 1 | 2015 | 113 | 0.030 |
Why?
|
| Cattle | 1 | 2015 | 565 | 0.030 |
Why?
|
| Radiography | 1 | 2016 | 821 | 0.030 |
Why?
|
| Disease-Free Survival | 1 | 2015 | 869 | 0.030 |
Why?
|
| Curriculum | 1 | 2018 | 727 | 0.030 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2015 | 1032 | 0.030 |
Why?
|
| Prosthesis Design | 1 | 2015 | 675 | 0.020 |
Why?
|
| Cohort Studies | 1 | 2021 | 4795 | 0.020 |
Why?
|
| Reoperation | 1 | 2015 | 832 | 0.020 |
Why?
|
| Heart Valve Prosthesis | 1 | 2015 | 301 | 0.020 |
Why?
|
| Swine | 1 | 2015 | 1177 | 0.020 |
Why?
|
| Blood Vessel Prosthesis | 1 | 2015 | 544 | 0.020 |
Why?
|
| Ultrasonography | 1 | 2016 | 932 | 0.020 |
Why?
|
| Prospective Studies | 1 | 2022 | 6135 | 0.020 |
Why?
|
| Obesity | 1 | 2021 | 2262 | 0.020 |
Why?
|
| Databases, Factual | 1 | 1994 | 1179 | 0.020 |
Why?
|
| Surveys and Questionnaires | 1 | 2018 | 3693 | 0.020 |
Why?
|
| Pregnancy | 1 | 2021 | 7183 | 0.020 |
Why?
|
| Genome, Human | 1 | 1994 | 1273 | 0.020 |
Why?
|
| Time Factors | 1 | 2015 | 6293 | 0.020 |
Why?
|
| Anti-Bacterial Agents | 1 | 2015 | 2426 | 0.010 |
Why?
|
| Plasma Membrane Neurotransmitter Transport Proteins | 1 | 2002 | 7 | 0.010 |
Why?
|
| Ion Transport | 1 | 2002 | 52 | 0.010 |
Why?
|
| Water-Electrolyte Balance | 1 | 2002 | 81 | 0.010 |
Why?
|
| Neurotransmitter Agents | 1 | 2002 | 146 | 0.010 |
Why?
|
| Protein Isoforms | 1 | 2002 | 406 | 0.010 |
Why?
|
| Communication | 1 | 2002 | 507 | 0.010 |
Why?
|
| Pilot Projects | 1 | 2002 | 1388 | 0.010 |
Why?
|
| CD-ROM | 1 | 1994 | 1 | 0.010 |
Why?
|
| Books | 1 | 1994 | 6 | 0.010 |
Why?
|
| Online Systems | 1 | 1994 | 13 | 0.010 |
Why?
|
| Computer Communication Networks | 1 | 1994 | 15 | 0.010 |
Why?
|
| DNA, Mitochondrial | 1 | 1994 | 211 | 0.010 |
Why?
|
| Risk Assessment | 1 | 2002 | 3445 | 0.010 |
Why?
|
| Chromosome Disorders | 1 | 1994 | 311 | 0.010 |
Why?
|
| Congenital Abnormalities | 1 | 1994 | 255 | 0.010 |
Why?
|
| Chromosome Aberrations | 1 | 1994 | 616 | 0.010 |
Why?
|
| Neoplasms | 1 | 1994 | 2772 | 0.000 |
Why?
|